Note: This manuscript was withdrawn by the authors due to administrative consent issues; however, the findings were subsequently validated and published in Cell Reports Medicine. This summary reflects the scientific content of the original preprint.
Introduction
While most children experience mild symptoms from SARS-CoV-2 infection, a subset develops Multisystem Inflammatory Syndrome in Children (MIS-C), a severe and potentially life-threatening condition occurring weeks after the initial infection. Distinguishing MIS-C from acute COVID-19 or other inflammatory conditions like Kawasaki Disease remains a clinical challenge. This study utilizes multi-omic "liquid biopsy" techniques to identify specific nucleic acid biomarkers that characterize the unique immune signatures and tissue damage patterns of MIS-C.
Methods: A Multi-Analyte Approach
The researchers employed a comprehensive three-dimensional profiling of blood samples:
- Whole Blood RNA (wbRNA): Captures gene expression in circulating white blood cells to monitor the active host immune response.
- Plasma Cell-Free RNA (cfRNA): Analyzes transcripts released into the plasma, likely from dying cells. Using BayesPrism deconvolution against the Tabula Sapiens cell atlas, these transcripts were mapped back to specific tissues of origin.
- Plasma Cell-Free DNA (cfDNA): Employs whole-genome bisulfite sequencing to analyze DNA methylation patterns, providing a "tissue-of-origin" (TOO) profile to quantify DNA shed from specific organs like the heart, liver, or lungs.
Datasets and Cohort Overview
The study analyzed 416 blood samples from 237 pediatric patients across three major US hospital systems: UCSF, Emory University/Children’s Healthcare of Atlanta, and Children’s National Hospital.
The cohort included 141 MIS-C patients, 70 acute COVID-19 patients, and 26 healthy controls. The researchers used the Tabula Sapiens human single-cell transcriptome atlas as a reference for their deconvolution algorithms.
Key Insights: Mapping the Damage
- Complementary Profiling: wbRNA and cfRNA provide distinct perspectives; wbRNA tracks the immune "offensive," while cfRNA reveals the "collateral damage" to solid organs.
- Unexpected Schwann Cell Involvement: A significant finding was the elevation of cfRNA from neuronal Schwann cells specifically in MIS-C, suggesting peripheral nervous system involvement.
- T-Cell Exhaustion: Unlike the strong antiviral interferon response seen in acute COVID-19, MIS-C was characterized by the downregulation of T-cell pathways, suggesting a state of immune exhaustion.
- Molecular Heterogeneity: MIS-C is characterized by highly variable damage across multiple organ systems (endothelium, liver, heart, kidney), reflecting its complex multisystem nature.
Key Results
The study identified several molecular hallmarks that differentiate MIS-C from acute COVID-19:
- Elevated cfDNA Load: MIS-C patients showed significantly higher total cfDNA levels (mean 4.12 ng/uL) compared to other groups, indicating more extensive cell death.
- Specific Biomarkers: The autoantigen TGM2 and endothelial markers like AKAP12 were significantly elevated in MIS-C cfRNA. Conversely, acute COVID-19 was dominated by interferon-stimulated genes such as ISG15 and RSAD2.
- T-Cell Receptor Signatures: MIS-C showed a unique upregulation of TRBV11-2, a T-cell receptor segment previously linked to superantigen-like effects.
Clinical Correlation and Limitations
Kidney-derived cfDNA concentrations correlated with clinical creatinine levels (R=0.40, p=0.004), validating the accuracy of these liquid biopsies in reflecting organ stress.
However, the study has limitations:
- Withdrawal Status: The preprint was withdrawn due to consent issues, though findings were later validated.
- Control Groups: The lack of a Kawasaki Disease control group limits the assessment of these biomarkers' specificity against similar inflammatory syndromes.
- Reference Atlas Dependency: The resolution of tissue-of-origin profiling depends on the comprehensiveness of the underlying single-cell atlases.
This research demonstrates the power of multi-omic liquid biopsies to provide a detailed map of the systemic impact of SARS-CoV-2 in children, offering a path toward more precise diagnosis and monitoring of MIS-C.
Summary updated